ICD-10-CM Billable Code

B02.34

Zoster scleritis

Clinical Classification Guidelines

Medical Intelligence & Overview

Zoster scleritis is a serious eye condition caused by the reactivation of the varicella-zoster virus, the same virus responsible for chickenpox and shingles. This condition involves inflammation of the sclera, the white outer layer of the eye, and is often associated with shingles ophthalmicus. Recognizing and understanding zoster scleritis is vital for timely management, as it can impact vision and overall eye health if left untreated.

Causes & Symptoms

Clinical Causes: Reactivation of the varicella-zoster virus in individuals who have previously had chickenpox or shingles A weakened immune system, which can be due to aging, illness, or immunosuppressive medications Viral spread from trigeminal nerve involvement, as the virus migrates along nerve pathways to the eye Potential recurrence in individuals with a history of shingles or persistent viral presence

Key Symptoms: Severe eye pain, often localized around the sclera Redness and inflammation of the sclera, leading to a noticeable discoloration Swelling around the eye and visible scleral edema Sensitivity to light (photophobia) Tearing or excessive tearing of the eye Decreased vision or blurred vision in affected eye Possible rash or lesions on the skin around the forehead, eyelids, or face, following the nerve distribution A burning or throbbing sensation in the affected area

Diagnostic & Treatment

Diagnosis Path: Diagnosis of zoster scleritis involves a comprehensive eye examination by an ophthalmologist. The clinician will evaluate the scleral inflammation, check for associated shingles lesions, and assess nerve involvement. Additional diagnostic tools like slit-lamp examination, corneal topography, and, in some cases, imaging studies (such as ultrasound or MRI) may be employed to determine the extent of inflammation and rule out other conditions. A detailed patient history, including prior episodes of shingles or chickenpox, is also critical for diagnosis.

Treatment Protocols: Treatment for zoster scleritis primarily focuses on controlling inflammation, managing viral infection, and alleviating symptoms. Common approaches include: - **Antiviral medications:** Such as acyclovir, valacyclovir, or famciclovir, to suppress the varicella-zoster virus - **Corticosteroids:** To reduce inflammation and prevent scleral damage, usually prescribed with caution under medical supervision - **Pain management:** Using over-the-counter pain relievers or appropriate prescription medications - **Supportive care:** Including cold compresses and maintaining eye hygiene - **Monitoring and follow-up:** Regular eye examinations to assess response to treatment and prevent complications In some cases, additional therapies like immunomodulators or surgical intervention might be necessary depending on disease severity and response to initial treatments. Prompt medical attention is essential to prevent potential complications such as scleral thinning, tissue damage, or vision loss.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is B02.34 a billable ICD-10 code?
Yes, B02.34 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report B02.34?
Clinical documentation must specify the nature of Zoster scleritis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

scleritis zoster